rs74416259

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2

The NM_001017.3(RPS13):​c.24-7T>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00227 in 1,613,924 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.0021 ( 1 hom., cov: 31)
Exomes 𝑓: 0.0023 ( 12 hom. )

Consequence

RPS13
NM_001017.3 splice_region, intron

Scores

2
Splicing: ADA: 0.0005039
2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: 2.40

Publications

2 publications found
Variant links:
Genes affected
RPS13 (HGNC:10386): (ribosomal protein S13) Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a ribosomal protein that is a component of the 40S subunit. The protein belongs to the S15P family of ribosomal proteins. It is located in the cytoplasm. The protein has been shown to bind to the 5.8S rRNA in rat. The gene product of the E. coli ortholog (ribosomal protein S15) functions at early steps in ribosome assembly. This gene is co-transcribed with two U14 small nucleolar RNA genes, which are located in its third and fifth introns. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. [provided by RefSeq, Jul 2008]
PIK3C2A (HGNC:8971): (phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha) The protein encoded by this gene belongs to the phosphoinositide 3-kinase (PI3K) family. PI3-kinases play roles in signaling pathways involved in cell proliferation, oncogenic transformation, cell survival, cell migration, and intracellular protein trafficking. This protein contains a lipid kinase catalytic domain as well as a C-terminal C2 domain, a characteristic of class II PI3-kinases. C2 domains act as calcium-dependent phospholipid binding motifs that mediate translocation of proteins to membranes, and may also mediate protein-protein interactions. The PI3-kinase activity of this protein is not sensitive to nanomolar levels of the inhibitor wortmanin. This protein was shown to be able to be activated by insulin and may be involved in integrin-dependent signaling. [provided by RefSeq, Jul 2008]
PIK3C2A Gene-Disease associations (from GenCC):
  • oculocerebrodental syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 11-17077484-A-G is Benign according to our data. Variant chr11-17077484-A-G is described in ClinVar as Likely_benign. ClinVar VariationId is 2641639.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 327 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001017.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RPS13
NM_001017.3
MANE Select
c.24-7T>C
splice_region intron
N/ANP_001008.1P62277

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RPS13
ENST00000525634.6
TSL:1 MANE Select
c.24-7T>C
splice_region intron
N/AENSP00000435777.1P62277
RPS13
ENST00000924890.1
c.24-7T>C
splice_region intron
N/AENSP00000594949.1
RPS13
ENST00000864174.1
c.24-7T>C
splice_region intron
N/AENSP00000534233.1

Frequencies

GnomAD3 genomes
AF:
0.00215
AC:
327
AN:
152028
Hom.:
1
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000338
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00216
Gnomad ASJ
AF:
0.0268
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.000661
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00244
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00264
AC:
661
AN:
250822
AF XY:
0.00262
show subpopulations
Gnomad AFR exome
AF:
0.000247
Gnomad AMR exome
AF:
0.00171
Gnomad ASJ exome
AF:
0.0272
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000929
Gnomad NFE exome
AF:
0.00248
Gnomad OTH exome
AF:
0.00344
GnomAD4 exome
AF:
0.00228
AC:
3337
AN:
1461778
Hom.:
12
Cov.:
31
AF XY:
0.00230
AC XY:
1672
AN XY:
727196
show subpopulations
African (AFR)
AF:
0.000478
AC:
16
AN:
33480
American (AMR)
AF:
0.00184
AC:
82
AN:
44686
Ashkenazi Jewish (ASJ)
AF:
0.0262
AC:
685
AN:
26122
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39698
South Asian (SAS)
AF:
0.000893
AC:
77
AN:
86246
European-Finnish (FIN)
AF:
0.000318
AC:
17
AN:
53418
Middle Eastern (MID)
AF:
0.00555
AC:
32
AN:
5764
European-Non Finnish (NFE)
AF:
0.00200
AC:
2220
AN:
1111974
Other (OTH)
AF:
0.00343
AC:
207
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
188
376
563
751
939
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
84
168
252
336
420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00215
AC:
327
AN:
152146
Hom.:
1
Cov.:
31
AF XY:
0.00195
AC XY:
145
AN XY:
74388
show subpopulations
African (AFR)
AF:
0.000337
AC:
14
AN:
41520
American (AMR)
AF:
0.00216
AC:
33
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.0268
AC:
93
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5164
South Asian (SAS)
AF:
0.000622
AC:
3
AN:
4824
European-Finnish (FIN)
AF:
0.000661
AC:
7
AN:
10590
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.00244
AC:
166
AN:
67972
Other (OTH)
AF:
0.00331
AC:
7
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
18
35
53
70
88
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00330
Hom.:
0
Bravo
AF:
0.00216
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00376
EpiControl
AF:
0.00368

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
CADD
Benign
14
DANN
Benign
0.77
PhyloP100
2.4
PromoterAI
-0.045
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00050
dbscSNV1_RF
Benign
0.092
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs74416259; hg19: chr11-17099031; API